Edwards’ SAPIEN M3 delivery system linked to patient death in FDA alert

Edwards Lifesciences' SAPIEN M3 transcatheter mitral valve replacement system delivery component has been linked to one patient death and one serious injury, according to an FDA alert issued as of October 5. The specific failure mode and scope of affected devices were not detailed in the available information.